Related Experiment Videos
Propentosylline depresses amyloid and Alzheimer's CSF microglial antigens after ischaemia
A McRae1, K A Rudolphi, P Schubert
1Hoechst AG, Frankfurt a.M., Germany.
Abstract:
In the gerbil hippocampus activated microglial antigens are intensely stained by cerebrospinal fluid from patients with Alzheimer's disease (AD-CSF), OX18 and the amyloid precursor protein (beta-APP) up to 14 days after ischaemia. Propentosylline (PPF), which facilitates the adenosine A2 receptor action, has been shown to be neuroprotective, to depress O2- radical formation in macrophages and to interfere with the generation of phagocytotic macrophages from cultivated microglial cells. In this report we tested in ischaemic gerbils whether PPF treatment influences the potential neurotoxic properties of microglia. Daily post-treatment with PPF, started 24 h after ischaemia, depressed the immunostaining of activated microglia by AD-CSF, OX18 and APP in the hippocampus. Thus, PPF may protect against microglia-related brain damage.
Insights
Propentosylline (PPF) treatment reduced microglial activation in gerbil brains following ischemia. This suggests PPF may protect against brain damage caused by microglia in Alzheimer's disease (AD) and ischemic conditions.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Alzheimer's disease cerebrospinal fluid (AD-CSF) intensely stains activated microglial antigens in the gerbil hippocampus post-ischemia.
- Microglia activation and amyloid precursor protein (APP) expression persist for up to 14 days after ischemia.
- Propentofylline (PPF) is known to be neuroprotective and modulate microglial activity.
Purpose of the Study:
- To investigate the effect of Propentofylline (PPF) on the neurotoxic properties of microglia in an ischemic gerbil model.
- To determine if PPF treatment influences microglial activation markers in the hippocampus after ischemia.
Main Methods:
- Gerbils were subjected to ischemia.
- Daily post-treatment with Propentofylline (PPF) was initiated 24 hours after ischemia.
- Immunohistochemistry was used to assess microglial activation markers (AD-CSF, OX18, APP) in the hippocampus.
Main Results:
- PPF treatment significantly depressed the immunostaining of activated microglia by AD-CSF, OX18, and APP in the hippocampus.
- These effects were observed up to 14 days after the ischemic event.
Conclusions:
- Propentofylline (PPF) treatment effectively reduces microglial activation in the ischemic gerbil hippocampus.
- PPF demonstrates potential as a therapeutic agent to mitigate microglia-related brain damage in conditions like Alzheimer's disease and ischemia.